InvestorsHub Logo
Followers 5214
Posts 24018
Boards Moderated 5
Alias Born 09/20/2000

Re: stervc post# 24940

Friday, 03/24/2017 11:54:07 AM

Friday, March 24, 2017 11:54:07 AM

Post# of 106828
USRM Compared to those 2 NASDAQ Companies Mentioned

With comparing USRM to those two other companies that have Phase III Heart Failure Therapies, both of those companies trade on the NASDAQ and trades at a few dollars per share; Meso Blast

To ”Compare & Contrast” to USRM

... Meso Blast trades on the NASDAQ under the ticker of MESO and has a Market Cap of $541,270,000+ at over $9.00+ per share:
http://finance.yahoo.com/quote/MESO/key-statistics?p=MESO

Cardio3 changed its name to Celyad and trades on the NASDAQ under the ticker of CYAD and has a Market Cap of $206,860,000+ at over $22.00+ per share:
https://www.google.com/search?q=CARDIO3&oq=CARDIO3&aqs=chrome..69i57&sourceid=chrome&ie=UTF-8
http://finance.yahoo.com/quote/CYAD/key-statistics?p=CYAD

I’m not going to say that such comparisons above is reason enough to believe that USRM should be trading in the dollars, but I think it’s reason enough to justify that USRM should be trading at some levels far higher than where we’re trading at right now. Just on potential alone, I believe the market will eventually realize what we realize.

Courtesy of TheHungryHippo, this post is very powerful that I believe all should read:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129037975

v/r
Sterling


Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531